首页> 外国专利> RADIOACTIVE MEDICAL DEVICES AND METHODS OF MAKING RADIOACTIVE MEDICAL DEVICES

RADIOACTIVE MEDICAL DEVICES AND METHODS OF MAKING RADIOACTIVE MEDICAL DEVICES

机译:放射医学设备和制造放射医学设备的方法

摘要

This invention involves radioactive medical devices for inhibiting an undesirable hyperplastic response in biological tissue, and a method for making the radioactive medical devices. In a first preferred embodiment (10), a medical device for inhibiting a hyperplastic response in biological tissue generally comprises polymeric hydrocarbon molecules forming the medical device (10) and a salt or an acid of a radioactive isotope occluded within the polymeric hydrocarbon molecules. In a second preferred embodiment (30), the medical device (30) comprises a thrombogenic sponge (42) having a radioisotope trapped within the structure of the sponge. Also in a preferred embodiment (10 or 30), a method of creating a medical device (10 or 30) according to the present invention comprises: providing a first solvent (12) in a container (11); introducing a salt or an acid of a radioactive isotope (16) into the first solvent (12); introducing a second solvent (18) into the first solution (17) so as to form a second solution (21); and introducing the medical device (10) into the second solution (21), wherein the ionic components of the radioactive isotope migrate into the molecular structure of the medical device (10). In another aspect, a method of creating a medical device (10) that inhibits a hyperplastic response in biological tissue comprises placing a salt or an acid of a radioactive isotope (16) in a fluid and permitting the salt or acid to disassociate in solution, submersing the sponge (42) in the solution and permitting the radioactive isotopes to become trapped in the structure of the sponge (42).
机译:本发明涉及用于抑制生物组织中不希望的增生反应的放射性医疗装置,以及制造该放射性医疗装置的方法。在第一优选实施例(10)中,用于抑制生物组织中增生性反应的医疗装置通常包括形成医疗装置(10)的聚合烃分子和在该聚合烃分子内闭塞的放射性同位素的盐或酸。在第二优选实施例(30)中,医疗装置(30)包括具有被形成在海绵的结构内的放射性同位素的血栓形成海绵(42)。另外,在优选的实施方式(10或30)中,根据本发明的制造医疗装置(10或30)的方法包括:在容器(11)中提供第一溶剂(12);以及在容器(11)中提供第一溶剂(12)。将放射性同位素(16)的盐或酸引入第一溶剂(12)中;将第二溶剂(18)引入第一溶液(17)以形成第二溶液(21);将医疗装置(10)引入第二溶液(21),其中放射性同位素的离子组分迁移到医疗装置(10)的分子结构中。在另一方面,一种产生抑制生物组织中增生反应的医疗装置(10)的方法包括将放射性同位素(16)的盐或酸置于流体中并使盐或酸在溶液中解离,将海绵(42)浸入溶液中,并使放射性同位素被困在海绵(42)的结构中。

著录项

  • 公开/公告号WO02100479A2

    专利类型

  • 公开/公告日2002-12-19

    原文格式PDF

  • 申请/专利权人 ISOTECH LLC;

    申请/专利号WO2002US18614

  • 发明设计人 GANNON BRIAN;ROSENTHAL DAVID;

    申请日2002-06-12

  • 分类号A61N;

  • 国家 WO

  • 入库时间 2022-08-21 23:55:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号